Enantioseparations by capillary electro-chromatography: differences exhibited by normal- and reversed-phase versions of polysaccharide stationary phases.
The influence of using normal-phase and reversed-phase versions of four commercial polysaccharide stationary phases on chiral separations was investigated with capillary electrochromatography (CEC). Both versions of the stationary phases, Chiralcel OD, OJ, and Chiralpak AD, AS were tested for the separation of two basic, two acidic, a bifunctional, and a neutral compound. Different background electrolytes were used, two at low pH for the acid, bifunctional and neutral substances, and three at high pH for the basic, bifunctional and neutral ones. This setup allowed evaluating differences between both stationary-phase versions and between mobile-phase compositions on a chiral separation. Duplicate CEC columns of each stationary phase were in-house prepared and tested, giving information about the intercolumn reproducibility. In general, reversed-phase versions of the current commercial polysaccharide stationary phases are found to be best for reversed-phase CEC, even though at high pH no significant differences were seen between both versions. Most differences were observed at low pH. For acidic compounds, it was seen that an ammonium formate electrolyte performed best, which is also an excellent electrolyte if coupling with mass spectrometry is desired. For basic, bifunctional and neutral compounds, no significant differences between the three tested electrolytes were observed at high pH. Here, a phosphate buffer is preferred as electrolyte because of its buffering capacities. However, if coupling to mass spectrometry is wanted, the more volatile ammonium bicarbonate electrolyte can be used as an alternative.
Mangelings
Debby
D
Department of Pharmaceutical and Biomedical Analysis, Pharmaceutical Institute, Vrije Universiteit Brussel-VUB, Brussels, Belgium.
Maftouh
Mohamed
M
Massart
D Luc
DL
Vander Heyden
Yvan
Y
D000688:Amylose / Q000031:analogs & derivatives*; D002219:Carbamates; D002482:Cellulose / Q000031:analogs & derivatives*; D020374:Chromatography, Micellar Electrokinetic Capillary / Q000379:methods*; D006863:Hydrogen-Ion Concentration; D007202:Indicators and Reagents; D010076:Oxazepam / Q000737:chemistry / Q000302:isolation & purification; D048448:Phenylcarbamates; D010869:Pindolol / Q000737:chemistry / Q000302:isolation & purification; D011134:Polysaccharides / Q000737:chemistry*; D011223:Praziquantel / Q000737:chemistry / Q000302:isolation & purification; D013237:Stereoisomerism; D013773:Tetramisole / Q000737:chemistry / Q000302:isolation & purification
D002219:Carbamates; D007202:Indicators and Reagents; D048448:Phenylcarbamates; D011134:Polysaccharides; C445088:chiralpak AS; C070231:Chiracel OJ; C065943:cellulose tris-3,5-dimethylphenyl-carbamate; C080033:Chiralpak AD; D011223:Praziquantel; D010076:Oxazepam; D002482:Cellulose; D000688:Amylose; D010869:Pindolol; D013773:Tetramisole